CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection

Immunology and Cell Biology

Volumn 81, Issue 2, 2003, Pages 114-120

  Rodriguez Sosa, Miriam ^a   Rosas, Lucia E ^b   Terrazas, Luis I ^a   Lu, Bao ^c   Gerard, Craig ^c   Satoskar, Abhay R ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CC chemokine receptor 1; Leishmania major; Th1 response; Th2 response

Indexed keywords

ANTIGEN; CHEMOKINE RECEPTOR CCR1; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EOSINOPHIL; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLAMMATION; LEISHMANIA MAJOR; LEUKOCYTE; LYMPH NODE CELL; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PROTOZOAL INFECTION; SKIN INFECTION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; CYTOKINES; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, CHEMOKINE; TH2 CELLS; TIME FACTORS;

ANIMALIA; LEISHMANIA MAJOR; PROTOZOA;

EID: 0037386239     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0818-9641.2002.01132.x     Document Type: Article

References (37)

1. Peters W, Killick-Kendrick R. The Leishmaniasis in Biology and Medicine, Vol. 1 and 2. London: Academic Press, 1987.
2. Heinzel FP, Sadick MD, Holaday B J, Coffman RL, Locksley RM. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 1989; 169: 59-72.
3. Heinzel FP, Schoenhaut DS, Reeko RM, Rosser LE, Gatley MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 1993; 177: 1505-9.
4. Sypek JP, Chung CL, Mayor SEH et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 1993; 177: 1797-802.
5. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995; 13: 151-77.
6. Baggiolin M, Dewald B, Moser B. Human chemokines: An update. Annu. Rev. Immunol. 1997; 15: 675-705.
7. Broxmeyer HE, Sherry B, Cooper S et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells: interacting effects involving suppression, synergistic suppression and blocking of suppression. J. Immunol. 1993; 150: 3448-58.
8. Graham GJ, Wright EG, Hewick R et al. Identification and characterization of an inhibitor of haematopoietic stem cell proliferation. Nature 1990; 344: 442-4.
9. Stricter RM, Polverini PJ, Arenberg DA et al. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J. Leukoc. Biol. 1995; 57: 752-62.
10. Ritter U, Moll H, Laksay T et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J. Infect. Dis. 1996; 173: 699-709.
11. Racoosin EL, Beverly SM. Leishmania major promastigotes induce expression of a subset of chemokine genes in murine macropbages. Exp. Parasitol. 1997; 85: 283-95.
12. Moll H. The role of chemokines and accessory cells in the immnnoregulation of cutaneous leishmaniasis. Behring Inst. Mitt. 1997; 99: 73-8.
13. Badolato R, Sacks DL, Savoia D, Musso T. Leishmania major infection of human monocytes induces expression of IL-8 and MCAF. Exp. Parasitol. 1996; 82: 21-6.
14. Vester B, Muller K, Solbach W, Laskay T. Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect. Immun. 1999; 67: 3155-9.
15. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000; 18: 593-620.
16. Neote KD, DiGregorio JY, Mak T, Horul R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415-25.
17. Gao J-L, Kuhns DB, Tiffany HL et al. Structure and functional expression of the human macrophage inflammatory protein-1α/RANTES receptor. J. Exp. Med. 1993; 177: 1421-7.
18. Combadiere C, Ahuja SK, Van Damme J, Tiffany HL, Gao J-L, Murphy PM. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J. Biol. Chem. 1995; 270: 29 671-5.
19. Topham PS, Cszmadia V, Soler D et al. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injmy during nephrotoxic nephritis. J. Clin. Invest. 1999; 104: 1549-57.
20. Gao JL, Wynn TA, Chang Y et al. Impaired host defense, hematopoiesis, granulomatous inflammation and typel-type 2 cytokine balance in mice lacking CC chemokine receptor I. J. Exp. Med. 1997; 185: 1959-68.
21. Satoskar AR, Stamm LM, Zhang X et al. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J. Immunol. 1999; 162: 6747-54.
22. Bonecchi R, Bianchi G, D'Ambrosio PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998; 187: 129-34.
23. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. Exp. Med. 1998; 187: 875-03.
24. Siveke JT, Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 1998; 160: 550-4.
25. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 lmmune response. J. Immunol. 1996; 157: 3598-604.
26. Behin R, Mauel J, Sordat B. Leishmania tropica: pathogenicity and in vitro macrophage function in strains on inbred mice. Exp. Parasitol. 1979; 48: 81-91.
27. Scharton TM, Scott P. Natural killer cells are a source of interferon-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993; 178: 567-77.
28. Doherty TM, Coffman RL. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitol. 1996; 84: 124-35.
29. Menon JN, Bretscher PA. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur. J. Immunol. 1998; 28: 4020-8.
30. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992; 257: 539-42.
31. Lira R, Doherty M, Modi G, Sacks D. Evolution of lesion formation, parasite load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect. Immun. 2000; 68: 5176-82.
32. Reiner SL, Zhang S, Zhang Z-E, Stowring L, Locksley RM. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 1994; 171: 447-56.
33. Soares MBP, David JR, Titus RG. An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect. Immun. 1997; 65: 2837-45.
34. Scharton-Kersten T, Scott P. The role of the innate immune response in Th1 cell development following Leishmania major infection. J. Leukoc. Biol. 1995; 57: 515-22.
35. Chatelain R, Varkila K, Coffman RL. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 1992; 148: 1182-7.
36. Leal LM, Moss DW, Kuhn R, Muller W, Liew FY. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 1993; 23: 566-9.
37. Sato N, Ahuja SK, Quinones M et al. CC chemokine receptor (CCR) 2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: Phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 2000; 192: 205-18.